Polymorphism in the Apo(a) gene predict responsiveness to acetylsalicylic acid treatment
US7943317B2 · kind B2 · utility
2Cited by
1References
21Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 9, 2008 |
| Grant date | May 17, 2011 |
| Priority date | — |
| Expiry date | May 1, 2029 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to nucleotide polymorphisms in the human Apo(a) gene and to the use of Apo(a) nucleotide polymorphisms in identifying whether a human subject will respond or not to treatment with acetylsalicylic acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.